Harte-Hanks (HHS) Misses Q2 EPS by 27c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.26 +3.90%
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q2 EPS of ($0.05), $0.27 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $38.6 million versus the consensus estimate of $47.5 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Agilent Technologies (A) Tops Q3 EPS by 13c, Beats on Revenue; Offers FY EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
